Animal Health Care
Animal Health Care market is segmented by players, region (country), by Type and by Application. ... Read More
1 Study Coverage 1.1 Animal Blood Plasma Products and Derivatives Product Introduction 1.2 Market by Type 1.2.1 Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Immunoglobulin 1.2.3 Fibrinogen 1.2.4 Serum Albumin 1.2.5 Fetal Bovine Serum 1.3 Market by Application 1.3.1 Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Cell Culture Media 1.3.3 Food Industry 1.3.4 Pharmaceutical Industry 1.3.5 Sports Nutrition 1.3.6 Nutrition Supplements 1.3.7 Cosmetic Industry 1.3.8 Diagnostic Industry 1.3.9 Pet Food Industry 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Animal Blood Plasma Products and Derivatives Sales Estimates and Forecasts 2017-2028 2.2 Global Animal Blood Plasma Products and Derivatives Revenue Estimates and Forecasts 2017-2028 2.3 Global Animal Blood Plasma Products and Derivatives Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Animal Blood Plasma Products and Derivatives Sales by Region 2.4.1 Global Animal Blood Plasma Products and Derivatives Sales by Region (2017-2022) 2.4.2 Global Sales Animal Blood Plasma Products and Derivatives by Region (2023-2028) 2.5 Global Animal Blood Plasma Products and Derivatives Revenue by Region 2.5.1 Global Animal Blood Plasma Products and Derivatives Revenue by Region (2017-2022) 2.5.2 Global Animal Blood Plasma Products and Derivatives Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Animal Blood Plasma Products and Derivatives Sales by Manufacturers 3.1.1 Global Top Animal Blood Plasma Products and Derivatives Manufacturers by Sales (2017-2022) 3.1.2 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Animal Blood Plasma Products and Derivatives in 2021 3.2 Global Animal Blood Plasma Products and Derivatives Revenue by Manufacturers 3.2.1 Global Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2017-2022) 3.2.2 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Animal Blood Plasma Products and Derivatives Revenue in 2021 3.3 Global Animal Blood Plasma Products and Derivatives Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Animal Blood Plasma Products and Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Animal Blood Plasma Products and Derivatives Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Animal Blood Plasma Products and Derivatives Sales by Type 4.1.1 Global Animal Blood Plasma Products and Derivatives Historical Sales by Type (2017-2022) 4.1.2 Global Animal Blood Plasma Products and Derivatives Forecasted Sales by Type (2023-2028) 4.1.3 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2017-2028) 4.2 Global Animal Blood Plasma Products and Derivatives Revenue by Type 4.2.1 Global Animal Blood Plasma Products and Derivatives Historical Revenue by Type (2017-2022) 4.2.2 Global Animal Blood Plasma Products and Derivatives Forecasted Revenue by Type (2023-2028) 4.2.3 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2017-2028) 4.3 Global Animal Blood Plasma Products and Derivatives Price by Type 4.3.1 Global Animal Blood Plasma Products and Derivatives Price by Type (2017-2022) 4.3.2 Global Animal Blood Plasma Products and Derivatives Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Animal Blood Plasma Products and Derivatives Sales by Application 5.1.1 Global Animal Blood Plasma Products and Derivatives Historical Sales by Application (2017-2022) 5.1.2 Global Animal Blood Plasma Products and Derivatives Forecasted Sales by Application (2023-2028) 5.1.3 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2017-2028) 5.2 Global Animal Blood Plasma Products and Derivatives Revenue by Application 5.2.1 Global Animal Blood Plasma Products and Derivatives Historical Revenue by Application (2017-2022) 5.2.2 Global Animal Blood Plasma Products and Derivatives Forecasted Revenue by Application (2023-2028) 5.2.3 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2017-2028) 5.3 Global Animal Blood Plasma Products and Derivatives Price by Application 5.3.1 Global Animal Blood Plasma Products and Derivatives Price by Application (2017-2022) 5.3.2 Global Animal Blood Plasma Products and Derivatives Price Forecast by Application (2023-2028) 6 North America 6.1 North America Animal Blood Plasma Products and Derivatives Market Size by Type 6.1.1 North America Animal Blood Plasma Products and Derivatives Sales by Type (2017-2028) 6.1.2 North America Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2028) 6.2 North America Animal Blood Plasma Products and Derivatives Market Size by Application 6.2.1 North America Animal Blood Plasma Products and Derivatives Sales by Application (2017-2028) 6.2.2 North America Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2028) 6.3 North America Animal Blood Plasma Products and Derivatives Market Size by Country 6.3.1 North America Animal Blood Plasma Products and Derivatives Sales by Country (2017-2028) 6.3.2 North America Animal Blood Plasma Products and Derivatives Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Animal Blood Plasma Products and Derivatives Market Size by Type 7.1.1 Europe Animal Blood Plasma Products and Derivatives Sales by Type (2017-2028) 7.1.2 Europe Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2028) 7.2 Europe Animal Blood Plasma Products and Derivatives Market Size by Application 7.2.1 Europe Animal Blood Plasma Products and Derivatives Sales by Application (2017-2028) 7.2.2 Europe Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2028) 7.3 Europe Animal Blood Plasma Products and Derivatives Market Size by Country 7.3.1 Europe Animal Blood Plasma Products and Derivatives Sales by Country (2017-2028) 7.3.2 Europe Animal Blood Plasma Products and Derivatives Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Animal Blood Plasma Products and Derivatives Market Size by Type 8.1.1 Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Type (2017-2028) 8.1.2 Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2028) 8.2 Asia Pacific Animal Blood Plasma Products and Derivatives Market Size by Application 8.2.1 Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Application (2017-2028) 8.2.2 Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2028) 8.3 Asia Pacific Animal Blood Plasma Products and Derivatives Market Size by Region 8.3.1 Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Region (2017-2028) 8.3.2 Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Animal Blood Plasma Products and Derivatives Market Size by Type 9.1.1 Latin America Animal Blood Plasma Products and Derivatives Sales by Type (2017-2028) 9.1.2 Latin America Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2028) 9.2 Latin America Animal Blood Plasma Products and Derivatives Market Size by Application 9.2.1 Latin America Animal Blood Plasma Products and Derivatives Sales by Application (2017-2028) 9.2.2 Latin America Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2028) 9.3 Latin America Animal Blood Plasma Products and Derivatives Market Size by Country 9.3.1 Latin America Animal Blood Plasma Products and Derivatives Sales by Country (2017-2028) 9.3.2 Latin America Animal Blood Plasma Products and Derivatives Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Size by Type 10.1.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Type (2017-2028) 10.1.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2028) 10.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Size by Application 10.2.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Application (2017-2028) 10.2.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2028) 10.3 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Size by Country 10.3.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Country (2017-2028) 10.3.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Lake Immunogenics 11.1.1 Lake Immunogenics Corporation Information 11.1.2 Lake Immunogenics Overview 11.1.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Lake Immunogenics Recent Developments 11.2 Auckland BioSciences 11.2.1 Auckland BioSciences Corporation Information 11.2.2 Auckland BioSciences Overview 11.2.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Auckland BioSciences Recent Developments 11.3 Kraeber & Co. GmbH 11.3.1 Kraeber & Co. GmbH Corporation Information 11.3.2 Kraeber & Co. GmbH Overview 11.3.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Kraeber & Co. GmbH Recent Developments 11.4 Sigma-Aldrich 11.4.1 Sigma-Aldrich Corporation Information 11.4.2 Sigma-Aldrich Overview 11.4.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Sigma-Aldrich Recent Developments 11.5 Thermo Fisher Scientific 11.5.1 Thermo Fisher Scientific Corporation Information 11.5.2 Thermo Fisher Scientific Overview 11.5.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Thermo Fisher Scientific Recent Developments 11.6 Rocky Mountain Biologicals 11.6.1 Rocky Mountain Biologicals Corporation Information 11.6.2 Rocky Mountain Biologicals Overview 11.6.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Rocky Mountain Biologicals Recent Developments 11.7 LAMPIRE Biological Laboratories 11.7.1 LAMPIRE Biological Laboratories Corporation Information 11.7.2 LAMPIRE Biological Laboratories Overview 11.7.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 LAMPIRE Biological Laboratories Recent Developments 11.8 Bovogen Biologicals 11.8.1 Bovogen Biologicals Corporation Information 11.8.2 Bovogen Biologicals Overview 11.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Bovogen Biologicals Recent Developments 11.9 Proliant 11.9.1 Proliant Corporation Information 11.9.2 Proliant Overview 11.9.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Proliant Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Proliant Recent Developments 11.10 ANZCO Foods 11.10.1 ANZCO Foods Corporation Information 11.10.2 ANZCO Foods Overview 11.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 ANZCO Foods Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 ANZCO Foods Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Animal Blood Plasma Products and Derivatives Industry Chain Analysis 12.2 Animal Blood Plasma Products and Derivatives Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Animal Blood Plasma Products and Derivatives Production Mode & Process 12.4 Animal Blood Plasma Products and Derivatives Sales and Marketing 12.4.1 Animal Blood Plasma Products and Derivatives Sales Channels 12.4.2 Animal Blood Plasma Products and Derivatives Distributors 12.5 Animal Blood Plasma Products and Derivatives Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Animal Blood Plasma Products and Derivatives Industry Trends 13.2 Animal Blood Plasma Products and Derivatives Market Drivers 13.3 Animal Blood Plasma Products and Derivatives Market Challenges 13.4 Animal Blood Plasma Products and Derivatives Market Restraints 14 Key Findings in The Global Animal Blood Plasma Products and Derivatives Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
List of Tables Table 1. Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Immunoglobulin Table 3. Major Manufacturers of Fibrinogen Table 4. Major Manufacturers of Serum Albumin Table 5. Major Manufacturers of Fetal Bovine Serum Table 6. Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Animal Blood Plasma Products and Derivatives Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Animal Blood Plasma Products and Derivatives Sales by Region (2017-2022) & (MT) Table 9. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2017-2022) Table 10. Global Animal Blood Plasma Products and Derivatives Sales by Region (2023-2028) & (MT) Table 11. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2023-2028) Table 12. Global Animal Blood Plasma Products and Derivatives Revenue by Region (2017-2022) & (US$ Million) Table 13. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2017-2022) Table 14. Global Animal Blood Plasma Products and Derivatives Revenue by Region (2023-2028) & (US$ Million) Table 15. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2023-2028) Table 16. Global Animal Blood Plasma Products and Derivatives Sales by Manufacturers (2017-2022) & (MT) Table 17. Global Animal Blood Plasma Products and Derivatives Sales Share by Manufacturers (2017-2022) Table 18. Global Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2017-2022) & (US$ Million) Table 19. Global Animal Blood Plasma Products and Derivatives Revenue Share by Manufacturers (2017-2022) Table 20. Animal Blood Plasma Products and Derivatives Price by Manufacturers (2017-2022) &(USD/Kg) Table 21. Global Animal Blood Plasma Products and Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Animal Blood Plasma Products and Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood Plasma Products and Derivatives as of 2021) Table 23. Animal Blood Plasma Products and Derivatives Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Animal Blood Plasma Products and Derivatives Product Offered Table 25. Date of Manufacturers Enter into Animal Blood Plasma Products and Derivatives Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Animal Blood Plasma Products and Derivatives Sales by Type (2017-2022) & (MT) Table 28. Global Animal Blood Plasma Products and Derivatives Sales by Type (2023-2028) & (MT) Table 29. Global Animal Blood Plasma Products and Derivatives Sales Share by Type (2017-2022) Table 30. Global Animal Blood Plasma Products and Derivatives Sales Share by Type (2023-2028) Table 31. Global Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2022) & (US$ Million) Table 32. Global Animal Blood Plasma Products and Derivatives Revenue by Type (2023-2028) & (US$ Million) Table 33. Global Animal Blood Plasma Products and Derivatives Revenue Share by Type (2017-2022) Table 34. Global Animal Blood Plasma Products and Derivatives Revenue Share by Type (2023-2028) Table 35. Animal Blood Plasma Products and Derivatives Price by Type (2017-2022) & (USD/Kg) Table 36. Global Animal Blood Plasma Products and Derivatives Price Forecast by Type (2023-2028) & (USD/Kg) Table 37. Global Animal Blood Plasma Products and Derivatives Sales by Application (2017-2022) & (MT) Table 38. Global Animal Blood Plasma Products and Derivatives Sales by Application (2023-2028) & (MT) Table 39. Global Animal Blood Plasma Products and Derivatives Sales Share by Application (2017-2022) Table 40. Global Animal Blood Plasma Products and Derivatives Sales Share by Application (2023-2028) Table 41. Global Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2022) & (US$ Million) Table 42. Global Animal Blood Plasma Products and Derivatives Revenue by Application (2023-2028) & (US$ Million) Table 43. Global Animal Blood Plasma Products and Derivatives Revenue Share by Application (2017-2022) Table 44. Global Animal Blood Plasma Products and Derivatives Revenue Share by Application (2023-2028) Table 45. Animal Blood Plasma Products and Derivatives Price by Application (2017-2022) & (USD/Kg) Table 46. Global Animal Blood Plasma Products and Derivatives Price Forecast by Application (2023-2028) & (USD/Kg) Table 47. North America Animal Blood Plasma Products and Derivatives Sales by Type (2017-2022) & (MT) Table 48. North America Animal Blood Plasma Products and Derivatives Sales by Type (2023-2028) & (MT) Table 49. North America Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2022) & (US$ Million) Table 50. North America Animal Blood Plasma Products and Derivatives Revenue by Type (2023-2028) & (US$ Million) Table 51. North America Animal Blood Plasma Products and Derivatives Sales by Application (2017-2022) & (MT) Table 52. North America Animal Blood Plasma Products and Derivatives Sales by Application (2023-2028) & (MT) Table 53. North America Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2022) & (US$ Million) Table 54. North America Animal Blood Plasma Products and Derivatives Revenue by Application (2023-2028) & (US$ Million) Table 55. North America Animal Blood Plasma Products and Derivatives Sales by Country (2017-2022) & (MT) Table 56. North America Animal Blood Plasma Products and Derivatives Sales by Country (2023-2028) & (MT) Table 57. North America Animal Blood Plasma Products and Derivatives Revenue by Country (2017-2022) & (US$ Million) Table 58. North America Animal Blood Plasma Products and Derivatives Revenue by Country (2023-2028) & (US$ Million) Table 59. Europe Animal Blood Plasma Products and Derivatives Sales by Type (2017-2022) & (MT) Table 60. Europe Animal Blood Plasma Products and Derivatives Sales by Type (2023-2028) & (MT) Table 61. Europe Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2022) & (US$ Million) Table 62. Europe Animal Blood Plasma Products and Derivatives Revenue by Type (2023-2028) & (US$ Million) Table 63. Europe Animal Blood Plasma Products and Derivatives Sales by Application (2017-2022) & (MT) Table 64. Europe Animal Blood Plasma Products and Derivatives Sales by Application (2023-2028) & (MT) Table 65. Europe Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2022) & (US$ Million) Table 66. Europe Animal Blood Plasma Products and Derivatives Revenue by Application (2023-2028) & (US$ Million) Table 67. Europe Animal Blood Plasma Products and Derivatives Sales by Country (2017-2022) & (MT) Table 68. Europe Animal Blood Plasma Products and Derivatives Sales by Country (2023-2028) & (MT) Table 69. Europe Animal Blood Plasma Products and Derivatives Revenue by Country (2017-2022) & (US$ Million) Table 70. Europe Animal Blood Plasma Products and Derivatives Revenue by Country (2023-2028) & (US$ Million) Table 71. Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Type (2017-2022) & (MT) Table 72. Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Type (2023-2028) & (MT) Table 73. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2022) & (US$ Million) Table 74. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Type (2023-2028) & (US$ Million) Table 75. Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Application (2017-2022) & (MT) Table 76. Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Application (2023-2028) & (MT) Table 77. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2022) & (US$ Million) Table 78. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Application (2023-2028) & (US$ Million) Table 79. Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Region (2017-2022) & (MT) Table 80. Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Region (2023-2028) & (MT) Table 81. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Region (2017-2022) & (US$ Million) Table 82. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Region (2023-2028) & (US$ Million) Table 83. Latin America Animal Blood Plasma Products and Derivatives Sales by Type (2017-2022) & (MT) Table 84. Latin America Animal Blood Plasma Products and Derivatives Sales by Type (2023-2028) & (MT) Table 85. Latin America Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2022) & (US$ Million) Table 86. Latin America Animal Blood Plasma Products and Derivatives Revenue by Type (2023-2028) & (US$ Million) Table 87. Latin America Animal Blood Plasma Products and Derivatives Sales by Application (2017-2022) & (MT) Table 88. Latin America Animal Blood Plasma Products and Derivatives Sales by Application (2023-2028) & (MT) Table 89. Latin America Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2022) & (US$ Million) Table 90. Latin America Animal Blood Plasma Products and Derivatives Revenue by Application (2023-2028) & (US$ Million) Table 91. Latin America Animal Blood Plasma Products and Derivatives Sales by Country (2017-2022) & (MT) Table 92. Latin America Animal Blood Plasma Products and Derivatives Sales by Country (2023-2028) & (MT) Table 93. Latin America Animal Blood Plasma Products and Derivatives Revenue by Country (2017-2022) & (US$ Million) Table 94. Latin America Animal Blood Plasma Products and Derivatives Revenue by Country (2023-2028) & (US$ Million) Table 95. Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Type (2017-2022) & (MT) Table 96. Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Type (2023-2028) & (MT) Table 97. Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Type (2017-2022) & (US$ Million) Table 98. Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Type (2023-2028) & (US$ Million) Table 99. Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Application (2017-2022) & (MT) Table 100. Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Application (2023-2028) & (MT) Table 101. Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Application (2017-2022) & (US$ Million) Table 102. Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Application (2023-2028) & (US$ Million) Table 103. Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Country (2017-2022) & (MT) Table 104. Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Country (2023-2028) & (MT) Table 105. Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Country (2017-2022) & (US$ Million) Table 106. Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Country (2023-2028) & (US$ Million) Table 107. Lake Immunogenics Corporation Information Table 108. Lake Immunogenics Description and Major Businesses Table 109. Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 110. Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications Table 111. Lake Immunogenics Recent Developments Table 112. Auckland BioSciences Corporation Information Table 113. Auckland BioSciences Description and Major Businesses Table 114. Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 115. Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications Table 116. Auckland BioSciences Recent Developments Table 117. Kraeber & Co. GmbH Corporation Information Table 118. Kraeber & Co. GmbH Description and Major Businesses Table 119. Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 120. Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications Table 121. Kraeber & Co. GmbH Recent Developments Table 122. Sigma-Aldrich Corporation Information Table 123. Sigma-Aldrich Description and Major Businesses Table 124. Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 125. Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications Table 126. Sigma-Aldrich Recent Developments Table 127. Thermo Fisher Scientific Corporation Information Table 128. Thermo Fisher Scientific Description and Major Businesses Table 129. Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 130. Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications Table 131. Thermo Fisher Scientific Recent Developments Table 132. Rocky Mountain Biologicals Corporation Information Table 133. Rocky Mountain Biologicals Description and Major Businesses Table 134. Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 135. Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications Table 136. Rocky Mountain Biologicals Recent Developments Table 137. LAMPIRE Biological Laboratories Corporation Information Table 138. LAMPIRE Biological Laboratories Description and Major Businesses Table 139. LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 140. LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications Table 141. LAMPIRE Biological Laboratories Recent Developments Table 142. Bovogen Biologicals Corporation Information Table 143. Bovogen Biologicals Description and Major Businesses Table 144. Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 145. Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications Table 146. Bovogen Biologicals Recent Developments Table 147. Proliant Corporation Information Table 148. Proliant Description and Major Businesses Table 149. Proliant Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 150. Proliant Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications Table 151. Proliant Recent Developments Table 152. ANZCO Foods Corporation Information Table 153. ANZCO Foods Description and Major Businesses Table 154. ANZCO Foods Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 155. ANZCO Foods Animal Blood Plasma Products and Derivatives Product Model Numbers, Pictures, Descriptions and Specifications Table 156. ANZCO Foods Recent Developments Table 157. Key Raw Materials Lists Table 158. Raw Materials Key Suppliers Lists Table 159. Animal Blood Plasma Products and Derivatives Distributors List Table 160. Animal Blood Plasma Products and Derivatives Customers List Table 161. Animal Blood Plasma Products and Derivatives Market Trends Table 162. Animal Blood Plasma Products and Derivatives Market Drivers Table 163. Animal Blood Plasma Products and Derivatives Market Challenges Table 164. Animal Blood Plasma Products and Derivatives Market Restraints Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Animal Blood Plasma Products and Derivatives Product Picture Figure 3. Global Animal Blood Plasma Products and Derivatives Market Share by Type in 2021 & 2028 Figure 3. Immunoglobulin Product Picture Figure 4. Fibrinogen Product Picture Figure 5. Serum Albumin Product Picture Figure 6. Fetal Bovine Serum Product Picture Figure 7. Global Animal Blood Plasma Products and Derivatives Market Share by Application in 2021 & 2028 Figure 8. Cell Culture Media Figure 9. Food Industry Figure 10. Pharmaceutical Industry Figure 11. Sports Nutrition Figure 12. Nutrition Supplements Figure 13. Cosmetic Industry Figure 14. Diagnostic Industry Figure 15. Pet Food Industry Figure 16. Animal Blood Plasma Products and Derivatives Report Years Considered Figure 17. Global Animal Blood Plasma Products and Derivatives Sales 2017-2028 (MT) Figure 18. Global Animal Blood Plasma Products and Derivatives Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 19. Global Animal Blood Plasma Products and Derivatives Revenue 2017-2028 (US$ Million) Figure 20. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 21. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2017-2022) Figure 22. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2023-2028) Figure 23. North America Animal Blood Plasma Products and Derivatives Sales YoY (2017-2028) & (MT) Figure 24. North America Animal Blood Plasma Products and Derivatives Revenue YoY (2017-2028) & (US$ Million) Figure 25. Europe Animal Blood Plasma Products and Derivatives Sales YoY (2017-2028) & (MT) Figure 26. Europe Animal Blood Plasma Products and Derivatives Revenue YoY (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Animal Blood Plasma Products and Derivatives Sales YoY (2017-2028) & (MT) Figure 28. Asia-Pacific Animal Blood Plasma Products and Derivatives Revenue YoY (2017-2028) & (US$ Million) Figure 29. Latin America Animal Blood Plasma Products and Derivatives Sales YoY (2017-2028) & (MT) Figure 30. Latin America Animal Blood Plasma Products and Derivatives Revenue YoY (2017-2028) & (US$ Million) Figure 31. Middle East & Africa Animal Blood Plasma Products and Derivatives Sales YoY (2017-2028) & (MT) Figure 32. Middle East & Africa Animal Blood Plasma Products and Derivatives Revenue YoY (2017-2028) & (US$ Million) Figure 33. The Animal Blood Plasma Products and Derivatives Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 34. The Top 5 and 10 Largest Manufacturers of Animal Blood Plasma Products and Derivatives in the World: Market Share by Animal Blood Plasma Products and Derivatives Revenue in 2021 Figure 35. Global Animal Blood Plasma Products and Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 36. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2017-2028) Figure 37. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2017-2028) Figure 38. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2017-2028) Figure 39. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2017-2028) Figure 40. North America Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2017-2028) Figure 41. North America Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2017-2028) Figure 42. North America Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2017-2028) Figure 43. North America Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2017-2028) Figure 44. North America Animal Blood Plasma Products and Derivatives Sales Share by Country (2017-2028) Figure 45. North America Animal Blood Plasma Products and Derivatives Revenue Share by Country (2017-2028) Figure 46. U.S. Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 47. Canada Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 48. Europe Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2017-2028) Figure 49. Europe Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2017-2028) Figure 50. Europe Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2017-2028) Figure 51. Europe Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2017-2028) Figure 52. Europe Animal Blood Plasma Products and Derivatives Sales Share by Country (2017-2028) Figure 53. Europe Animal Blood Plasma Products and Derivatives Revenue Share by Country (2017-2028) Figure 54. Germany Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 55. France Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 56. U.K. Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 57. Italy Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 58. Russia Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 59. Asia Pacific Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2017-2028) Figure 60. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2017-2028) Figure 61. Asia Pacific Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2017-2028) Figure 62. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2017-2028) Figure 63. Asia Pacific Animal Blood Plasma Products and Derivatives Sales Share by Region (2017-2028) Figure 64. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue Share by Region (2017-2028) Figure 65. China Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 66. Japan Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 67. South Korea Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 68. India Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 69. Australia Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 70. Taiwan Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 71. Indonesia Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 72. Thailand Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 73. Malaysia Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 74. Philippines Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 75. Latin America Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2017-2028) Figure 76. Latin America Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2017-2028) Figure 77. Latin America Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2017-2028) Figure 78. Latin America Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2017-2028) Figure 79. Latin America Animal Blood Plasma Products and Derivatives Sales Share by Country (2017-2028) Figure 80. Latin America Animal Blood Plasma Products and Derivatives Revenue Share by Country (2017-2028) Figure 81. Mexico Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 82. Brazil Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 83. Argentina Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 84. Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2017-2028) Figure 85. Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2017-2028) Figure 86. Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2017-2028) Figure 87. Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2017-2028) Figure 88. Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Share by Country (2017-2028) Figure 89. Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue Share by Country (2017-2028) Figure 90. Turkey Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 91. Saudi Arabia Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 92. U.A.E Animal Blood Plasma Products and Derivatives Revenue (2017-2028) & (US$ Million) Figure 93. Animal Blood Plasma Products and Derivatives Value Chain Figure 94. Animal Blood Plasma Products and Derivatives Production Process Figure 95. Channels of Distribution Figure 96. Distributors Profiles Figure 97. Bottom-up and Top-down Approaches for This Report Figure 98. Data Triangulation Figure 99. Key Executives Interviewed
Lake Immunogenics Auckland BioSciences Kraeber & Co. GmbH Sigma-Aldrich Thermo Fisher Scientific Rocky Mountain Biologicals LAMPIRE Biological Laboratories Bovogen Biologicals Proliant ANZCO Foods
Animal Health Care market is segmented by players, region (country), by Type and by Application. ... Read More
Anthocyanins market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More
Anticancer Drugs market is segmented by Type and by Application. Players, stakeholders, and other ... Read More
Anti-collision Sensor market is segmented by Type and by Application. Players, stakeholders, and ... Read More